Sirunya Silapunt is a Dermatology physician affiliated with The University of Texas Health Science Center at Houston. OpenAlex indexes 118 publications with 2,772 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6500 West Loop S Ste 200a
Bellaire, TX 774013535
Telephone
713-500-8334Provider last certified this registry record 28 Oct 2025.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- Amgen Inc.Program year20254 payments
- GENZYME CORPORATIONProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
39.9%Azole Antifungal25.3%Ketoconazole100%Part D≥78 patientsTetracycline-class Drug7.5%Doxycycline Monohydrate65%Doxycycline Hyclate35%Part D≥16 patients+ 2 more classes in this area
Sensory organs
19.1%Corticosteroid19.1%Hydrocortisone65%Clobetasol Propionate35%Part D≥36 patientsDermatology
17.1%Corticosteroid17.1%Triamcinolone Acetonide84%Fluocinolone Acetonide16%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PD‐1 inhibitors for cutaneous squamous cell carcinoma: A meta‐analysis
Australasian Journal of Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Frank Arnett, MD
The University of Texas Health Science Center at Houston
Ali Marian, MD
The University of Texas Health Science Center at Houston
Anjail Sharrief, MD
The University of Texas Health Science Center at Houston
Heidi Russell, MD
The University of Texas Health Science Center at Houston
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”